Louis Monti
Corporate Officer/Principal bei VISTAGEN THERAPEUTICS, INC.
Profil
Louis Monti is a member of the New York Academy of Sciences, the American Society of Clinical Psychopharmacology, and the International Brain Research Organization.
He is currently the Vice President of Translational Medicine at VistaGen Therapeutics, Inc. Dr. Monti was previously the President and CEO of Pherin Pharmaceuticals, Inc. from 2018 to 2020.
He holds a doctorate degree from the University of Utah and Universidad De La Republica Uruguay.
Aktive Positionen von Louis Monti
| Unternehmen | Position | Beginn |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2020 |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| American Society of Clinical Psychopharmacology | Corporate Officer/Principal | - |
| International Brain Research Organization | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Louis Monti
| Unternehmen | Position | Ende |
|---|---|---|
Pherin Pharmaceuticals, Inc.
 Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA. | Vorstandsvorsitzender | 01.11.2020 |
Ausbildung von Louis Monti
| University of Utah | Doctorate Degree |
| Universidad De La Republica Uruguay | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VISTAGEN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Pherin Pharmaceuticals, Inc.
Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA. | Health Technology |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
| American Society of Clinical Psychopharmacology | |
| International Brain Research Organization |
